Complete Filing Data
CervoMed Inc. reported Operating Income Loss of -$28.29 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean CervoMed Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$27.0M | -$16.3M | -$2.2M | -$5.8M | -$24.1M | -$14.2M | -$11.8M | -$18.4M | -$1.4M | -$18.0M | -$6.7M | -$14.4M | -$2.5M | -$15.8M | -$8.4M |
| Revenue * | $4.0M | $9.7M | $7.1M | $0.00 | $570.5K | $40.2K | |||||||||
| Operating Income Loss | -$28.3M | -$18.2M | -$7.8M | -$3.5M | -$24.7M | -$16.0M | -$11.6M | -$19.0M | -$11.3M | -$18.4M | -$6.4M | -$14.6M | -$12.8M | -$16.4M | -$7.6M |
| General And Administrative Expense | $10.5M | $9.2M | $6.5M | $2.1M | $7.4M | $6.4M | $4.8M | $6.2M | $6.2M | $11.1M | $2.5M | $4.8M | $7.3M | $6.7M | $2.2M |
| Research And Development Expense | $21.8M | $18.8M | $8.4M | $1.3M | $8.5M | $9.4M | $6.6M | $5.8M | $5.1M | $7.3M | $3.9M | $2.9M | $342.9K | ||
| Nonoperating Income Expense | $1.3M | $1.9M | $5.6M | -$2.3M | $6.4K | -$2.6M | $9.8M | $592.2K | -$772.6K | ||||||
| Interest Income Expense Nonoperating Net | $380.8K | $137.5K | $114.3K | $85.3K | $151.6K | -$48.0K | -$29.7K | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$15.6M | -$24.5M | -$15.9M | -$11.5M | -$18.8M | -$2.4M | -$18.4M | -$6.7M | -$17.2M | -$3.0M | |||||
| Other Nonoperating Income Expense | -$8.3K | -$991.00 | $5.4M | -$2.4M | $6.4K | $25.4K | -$660.6K | ||||||||
| Income Tax Expense Benefit | $0.00 | -$443.9K | -$1.7M | $332.9K | -$437.3K | -$1.1M | -$364.8K | $0.00 | -$2.8M | ||||||
| Interest Expense | $0.00 | $587.00 | $29.7K | $313.1K | $273.5K | $126.5K | |||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$50.4K | $56.2K | $0.00 | -$35.4K | $0.00 | ||||||||||
| Comprehensive Income Net Of Tax | -$27.0M | -$16.2M | -$2.2M | -$15.6M | -$24.1M | ||||||||||
| Deferred Income Tax Expense Benefit | $0.00 | -$443.9K | -$1.7M | $332.9K | -$437.3K | -$1.1M | -$364.8K | $0.00 | -$2.8M | ||||||
| Gross Profit | -$1.7M | -$170.2K | |||||||||||||
| Cost Of Revenue | $2.3M | $210.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q3 2011 | Q2 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$7.7M | -$6.3M | -$4.9M | -$4.8M | -$2.3M | -$2.5M | $2.2M | -$1.4M | -$534.3K | -$882.6K | -$4.2M | -$4.5M | -$12.2M | -$3.8M | -$4.6M | -$4.4M | -$3.1M | -$2.6M | -$2.8M | -$2.5M | -$2.7M | -$6.7M | -$2.8M | -$3.3M | $5.1M | $20.4M | -$28.6M | -$5.4M | -$3.8M | -$6.2M | -$1.4M | -$1.3M | -$1.2M | -$3.4M | -$4.5M | -$1.4M | -$1.5M | $2.3M | -$2.5M | -$3.5M | -$1.3M | -$4.3M | -$2.1M | -$1.8M | -$1.8M | |
| Revenue * | $322.6K | $1.8M | $1.9M | $1.9M | $3.3M | $2.3M | $1.5M | $1.7M | $1.4M | $0.00 | $0.00 | $0.00 | $0.00 | $143.3K | $143.3K | $250.2K | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Operating Income Loss | -$8.0M | -$6.6M | -$5.3M | -$5.4M | -$3.0M | -$2.6M | -$2.7M | -$1.2M | -$1.4M | -$904.1K | -$4.2M | -$4.6M | -$12.7M | -$3.8M | -$4.7M | -$5.3M | -$3.7M | $3.0M | -$3.1M | -$2.6M | -$2.9M | -$7.0M | -$3.1M | -$3.4M | -$3.3M | -$3.0M | -$2.6M | -$5.8M | -$3.8M | -$6.2M | -$1.3M | -$1.3M | -$1.2M | -$3.5M | -$1.8M | -$1.4M | -$1.7M | -$8.1M | -$2.1M | -$3.4M | -$3.4M | -$4.1M | -$2.1M | -$1.6M | -$1.8M | |
| General And Administrative Expense | $2.3M | $3.3M | $2.4M | $2.2M | $2.5M | $2.1M | $2.4M | $992.6K | $1.0M | $573.5K | $2.1M | $2.1M | $1.9M | $1.8M | $1.7M | $2.1M | $1.5M | $1.4M | $1.3M | $1.1M | $1.2M | $1.6M | $1.7M | $1.5M | $1.6M | $1.8M | $1.6M | $3.9M | $2.3M | $3.9M | $422.0K | $347.1K | $458.8K | $1.9M | $1.2M | $1.0M | $448.5K | $514.0K | $624.7K | $1.1M | $1.1M | $2.6M | $1.1M | $510.8K | $641.9K | |
| Research And Development Expense | $6.0M | $5.1M | $4.8M | $5.1M | $3.8M | $2.8M | $1.8M | $2.0M | $1.8M | $330.5K | $2.1M | $2.4M | $2.1M | $2.0M | $2.9M | $3.1M | $2.2M | $1.5M | $1.7M | $1.5M | $1.7M | $1.2M | $1.4M | $1.8M | $1.8M | $1.2M | $1.0M | $1.9M | $1.4M | $2.4M | $922.2K | $948.8K | $731.9K | $1.3M | $266.9K | $169.3K | ||||||||||
| Nonoperating Income Expense | $317.6K | $357.9K | $408.9K | $642.7K | $678.2K | $80.6K | $4.8M | -$194.5K | $892.0K | $21.4K | $1.2K | $1.6K | $2.5K | -$83.5K | -$2.8M | -$8.7K | $36.1K | $10.6M | $257.3K | -$38.3K | -$2.1M | -$195.7K | -$88.8K | -$189.4K | -$17.9K | |||||||||||||||||||||
| Interest Income Expense Nonoperating Net | $179.5K | $173.9K | $124.7K | $55.4K | $27.8K | $50.7K | $55.2K | $40.4K | $29.2K | $25.9K | -$34.1K | $22.0K | $16.9K | $20.7K | $38.0K | $45.3K | $37.5K | $1.3K | -$18.9K | -$55.7K | -$1.4K | |||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.8M | -$12.6M | -$3.8M | -$4.6M | -$5.2M | -$3.6M | -$2.9M | -$3.0M | -$2.6M | -$2.9M | -$6.9M | -$3.0M | -$3.3M | $5.1M | $20.4M | -$5.8M | -$1.4M | -$4.0M | -$3.6M | -$4.6M | ||||||||||||||||||||||||||
| Other Nonoperating Income Expense | -$1.2K | -$10.3K | -$135.00 | -$3.4K | -$247.00 | -$30.00 | $4.8M | -$212.2K | $856.6K | -$88.00 | $1.2K | $1.6K | $2.5K | $3.2K | $2.5K | $49.6K | $49.4K | -$17.6K | -$2.6K | -$133.8K | ||||||||||||||||||||||||||
| Income Tax Expense Benefit | $0.00 | -$400.0K | -$443.9K | $0.00 | -$805.7K | -$507.3K | -$362.4K | -$226.0K | -$108.9K | -$150.4K | -$214.5K | -$267.9K | -$364.8K | -$146.0K | -$186.5K | |||||||||||||||||||||||||||||||
| Interest Expense | $18.9K | $55.7K | $1.4K | $6.2K | $21.00 | $76.2K | $33.3K | $50.8K | $86.7K | $136.6K | $58.3K | $13.4K | $35.1K | -$23.0K | -$52.3K | |||||||||||||||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $6.6K | -$22.0K | -$35.0K | $142.9K | -$19.7K | $0.00 | $0.00 | $0.00 | $32.3K | -$372.00 | -$36.9K | -$49.7K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax | -$7.7M | -$6.3M | -$4.9M | -$4.6M | -$2.3M | -$2.5M | $2.2M | -$1.4M | -$4.1M | -$2.8M | -$4.2M | -$4.6M | -$12.2M | -$3.8M | -$4.6M | |||||||||||||||||||||||||||||||
| Deferred Income Tax Expense Benefit | -$362.4K | -$150.4K | ||||||||||||||||||||||||||||||||||||||||||||
| Gross Profit | $0.00 | $0.00 | $0.00 | $142.5K | $142.5K | -$3.6K | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||
| Cost Of Revenue | $0.00 | $0.00 | $0.00 | $850.00 | $850.00 | $253.8K | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $18.2M | $39.2M | $7.4M | -$33.3M | $34.9M | $24.8M | $20.1M | $15.6M | $21.2M | $9.2M | -$41.6K | $38.2M | $6.5M | -$18.4M | ||
| Cash And Cash Equivalents At Carrying Value | $8.2M | $9.0M | $7.8M | $4.1M | $37.3M | $18.5M | $14.2M | $8.9M | $1.6M | $2.0M | $2.3M | $255.0K | $312.1K | |||
| Liabilities And Stockholders Equity | $22.9M | $43.1M | $10.0M | $4.2M | $37.8M | $27.7M | $24.1M | $18.2M | $26.1M | $17.5M | $2.3M | $42.8M | $18.3M | $5.6M | ||
| Retained Earnings Accumulated Deficit | -$97.7M | -$70.7M | -$54.4M | -$52.3M | -$130.0M | -$105.9M | -$91.7M | -$79.9M | -$61.6M | -$60.2M | -$42.2M | -$75.3M | -$60.9M | |||
| Assets | $22.9M | $43.1M | $10.0M | $4.2M | $37.8M | $27.7M | $24.1M | $18.2M | $26.1M | $17.5M | $2.3M | $42.8M | $18.3M | $5.6M | ||
| Accounts Payable Current | $1.5M | $1.5M | $662.5K | $97.3K | $947.5K | $545.8K | $1.3M | $198.8K | $512.0K | $1.7M | $424.7K | $417.3K | $1.5M | $903.3K | ||
| Common Stock Value | $9.3K | $8.7K | $5.7K | $518.00 | $2.0K | $64.0K | $33.5K | $3.4K | $968.00 | $10.3K | $8.1K | $18.6K | $5.8K | |||
| Assets Current | $22.9M | $43.1M | $10.0M | $4.2M | $37.8M | $18.8M | $14.6M | $8.9M | $9.7M | $1.6M | $2.0M | $24.2M | $3.0M | $613.2K | ||
| Liabilities | $4.7M | $3.9M | $2.6M | $13.2M | $2.9M | $2.9M | $4.0M | $2.6M | $4.9M | $8.3M | $2.3M | $4.6M | $11.9M | $3.8M | $5.6M | |
| Liabilities Current | $4.7M | $3.9M | $2.4M | $1.7M | $804.0K | $2.7M | $4.4M | $1.5M | $2.3M | $8.9M | $4.9M | |||||
| Additional Paid In Capital Common Stock | $130.7M | $111.8M | $95.5M | $82.8M | $69.4M | $42.1M | $113.4M | $67.4M | ||||||||
| Property Plant And Equipment Net | $0.00 | $149.2K | $252.4K | $350.3K | $460.7K | $79.8K | $52.0K | $102.3K | $11.3K | $10.1K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.1M | $6.7M | $18.5M | $14.2M | $8.0M | |||||||||||
| Other Assets Noncurrent | $0.00 | $7.8K | $0.00 | $15.6K | $15.8K | $322.3K | $298.5K | $450.5K | $232.7K | $181.5K | ||||||
| Cash And Cash Equivalents Period Increase Decrease | $6.2M | -$905.3K | $7.3M | -$444.3K | -$339.3K | $21.6M | -$57.1K | $98.4K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$764.0K | $1.2M | $3.7M | -$2.6M | $18.8M | $4.3M | $6.2M | |||||||||
| Goodwill | $0.00 | $6.9M | $6.9M | $985.0K | $12.1M | $7.6M | ||||||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $0.00 | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | ||||||||||
| Marketable Securities Current | $12.6M | $29.9M | $0.00 | $0.00 | ||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $5.8K | $56.2K | $0.00 | $0.00 | ||||||||||||
| Marketable Securities Unrealized Gain Loss | $56.2K | $0.00 | -$35.4K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q4 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $26.0M | $33.4M | $34.6M | $45.6M | $50.0M | $5.3M | $7.4M | $9.6M | -$35.1M | -$33.7M | -$33.3M | $24.1M | $26.7M | $30.6M | $38.1M | $50.2M | $53.6M | $24.8M | $28.7M | $32.9M | $17.9M | $13.5M | $16.2M | $13.0M | $20.9M | $27.3M | $29.7M | $6.4M | $1.2M | -$19.1M | $11.5M | $14.0M | $16.6M | $19.1M | $31.8M | $35.3M | $42.8M | $45.3M | $12.2M | -$6.3M | -$8.5M | -$18.4M | -$6.0M | -$143.4K | $5.1M | $8.7M | $20.2K | |||||||||
| Cash And Cash Equivalents At Carrying Value | $9.4M | $8.3M | $10.5M | $7.7M | $10.0M | $6.4M | $10.4M | $15.0M | $14.6M | $6.6M | $6.0M | $9.9M | $40.3M | $43.3M | $46.6M | $21.9M | $25.6M | $10.8M | $6.1M | $8.4M | $5.3M | $8.0M | $11.0M | $12.9M | $16.2M | $1.2M | $7.4M | $12.2M | $3.0M | $3.0M | $5.9M | $1.9M | $2.9M | $3.9M | $23.8M | $27.1M | $222.1K | $255.6K | $78.6K | $111.4K | $156.9K | $42.9K | $98.4K | $2.1M | $5.9M | $0.00 | $13.0K | $58.3K | $0.00 | |||||||
| Liabilities And Stockholders Equity | $30.6M | $38.1M | $38.6M | $48.9M | $53.2M | $8.0M | $12.0M | $3.4M | $3.9M | $26.3M | $29.2M | $33.6M | $40.9M | $52.7M | $56.2M | $31.9M | $36.0M | $21.1M | $16.2M | $18.9M | $16.0M | $23.6M | $29.9M | $33.4M | $28.3M | $33.9M | $36.3M | $19.0M | $19.9M | $22.9M | $23.4M | $36.7M | $39.6M | $50.5M | $54.5M | $26.5M | $3.2M | $197.5K | $2.4M | $3.9M | $3.7M | $9.1M | $12.5M | |||||||||||||
| Retained Earnings Accumulated Deficit | -$89.6M | -$81.9M | -$75.6M | -$64.0M | -$59.3M | -$57.0M | -$52.1M | -$54.2M | -$52.8M | -$141.5M | -$138.7M | -$134.5M | -$126.5M | -$114.3M | -$110.6M | -$101.8M | -$97.4M | -$94.3M | -$88.0M | -$85.2M | -$82.7M | -$74.4M | -$67.6M | -$64.9M | -$63.3M | -$68.4M | -$88.8M | -$57.6M | -$52.2M | -$48.4M | -$96.0M | -$82.8M | -$78.8M | -$70.2M | -$66.8M | -$62.5M | -$60.0M | -$56.4M | -$56.7M | -$51.6M | -$42.2M | -$34.7M | -$30.3M | -$26.5M | ||||||||||||
| Assets | $30.6M | $38.1M | $38.6M | $48.9M | $53.2M | $8.0M | $12.0M | $3.4M | $3.9M | $26.3M | $29.2M | $33.6M | $40.9M | $52.7M | $56.2M | $31.9M | $36.0M | $21.1M | $16.2M | $18.9M | $16.0M | $23.6M | $29.9M | $33.4M | $28.3M | $33.9M | $36.3M | $19.0M | $19.9M | $22.9M | $23.4M | $36.7M | $39.6M | $50.5M | $54.5M | $26.4M | $3.2M | $197.0K | $2.4M | $3.9M | $3.7M | $9.1M | $12.5M | |||||||||||||
| Accounts Payable Current | $1.3M | $1.8M | $1.9M | $1.1M | $725.9K | $679.7K | $533.8K | $932.4K | $971.5K | $807.4K | $846.0K | $813.2K | $678.0K | $749.9K | $952.9K | $1.4M | $1.4M | $655.3K | $502.5K | $489.1K | $480.0K | $129.1K | $175.8K | $419.1K | $409.4K | $1.0M | $557.6K | $757.5K | $1.0M | $1.1M | $240.4K | $337.6K | $301.7K | $105.5K | $252.1K | $1.6M | $1.5M | $1.4M | $1.2M | $971.7K | $789.0K | $594.2K | $627.1K | |||||||||||||
| Common Stock Value | $9.3K | $9.3K | $8.7K | $8.3K | $8.3K | $6.2K | $5.7K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $101.9K | $101.9K | $101.9K | $64.0K | $64.0K | $34.6K | $4.7K | $4.7K | $3.4K | $50.6K | $50.6K | $50.5K | $14.5K | $12.3K | $10.3K | $10.3K | $103.5K | $102.4K | $18.6K | $18.6K | $18.6K | $18.5K | $18.4K | $8.7K | $421.0K | $400.2K | $89.1K | $90.3K | $88.2K | $77.9K | $75.6K | $64.1K | ||||||||||||
| Assets Current | $30.6M | $38.1M | $38.6M | $48.8M | $47.3M | $8.0M | $11.8M | $18.4M | $26.3M | $29.2M | $33.6M | $40.7M | $43.9M | $47.3M | $22.7M | $26.7M | $11.7M | $6.7M | $9.4M | $6.4M | $11.6M | $13.7M | $17.1M | $12.2M | $17.7M | $20.6M | $3.3M | $3.2M | $6.3M | $15.6M | $17.8M | $21.0M | $26.0M | $29.4M | $2.7M | $3.2M | $165.5K | $461.6K | $733.6K | $186.0K | $3.5M | $7.0M | ||||||||||||||
| Liabilities | $4.6M | $4.6M | $3.9M | $3.2M | $3.2M | $2.7M | $2.5M | $14.2M | $2.1M | $2.7M | $2.5M | $2.6M | $3.2M | $3.1M | $3.2M | $2.7M | $2.8M | $3.0M | $2.7M | $2.6M | $3.6M | $22.0M | $32.7M | $55.5M | $7.6M | $5.9M | $6.3M | $4.3M | $4.8M | $4.4M | $7.7M | $9.2M | $9.6M | $8.8M | $4.0M | $3.8M | ||||||||||||||||||||
| Liabilities Current | $2.3M | $2.5M | $3.0M | $2.9M | $2.7M | $2.1M | $2.1M | $2.7M | $1.8M | $1.3M | $1.2M | $1.0M | $1.2M | $945.7K | $688.0K | $1.4M | $18.7M | $29.5M | $51.6M | $3.7M | $1.8M | $2.2M | $2.0M | $2.6M | $2.1M | $3.0M | $4.1M | $10.7M | $9.6M | $8.8M | $20.9M | $10.0M | $3.8M | $3.3M | $3.2M | |||||||||||||||||||||
| Additional Paid In Capital Common Stock | $165.7M | $165.5M | $165.2M | $164.9M | $164.6M | $164.4M | $164.1M | $130.5M | $130.2M | $112.1M | $101.5M | $101.3M | $95.6M | $95.2M | $94.9M | $94.5M | $69.7M | $69.6M | $69.7M | $69.1M | $66.1M | $64.9M | $115.1M | $114.6M | $114.0M | $113.0M | $112.1M | $74.7M | $53.3M | $47.5M | $38.2M | $45.4M | $42.0M | $39.6M | $39.0M | $27.2M | ||||||||||||||||||||
| Property Plant And Equipment Net | $81.9K | $101.0K | $124.8K | $174.1K | $198.3K | $225.3K | $279.4K | $297.6K | $332.0K | $379.2K | $405.9K | $432.6K | $479.6K | $479.7K | $79.5K | $85.6K | $91.4K | $103.7K | $63.4K | $68.8K | $115.3K | $54.4K | $56.3K | $81.6K | $24.5K | $31.9K | $49.0K | $48.5K | $78.1K | $126.1K | $87.6K | |||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.5M | $9.0M | $7.7M | $10.0M | $6.4M | $7.8M | $10.4M | $649.8K | $2.6M | $4.8M | $6.0M | $9.9M | $40.3M | $43.3M | $46.6M | $21.9M | $25.6M | $10.8M | $6.1M | $8.4M | ||||||||||||||||||||||||||||||||||||
| Other Assets Noncurrent | $73.9K | $56.2K | $31.9K | $194.4K | $0.00 | $0.00 | $0.00 | $15.6K | $15.6K | $15.6K | $252.1K | $252.1K | $252.6K | $290.7K | $291.2K | $319.7K | $263.5K | $262.2K | $275.7K | $38.8K | $157.2K | $63.8K | $106.6K | $166.9K | $134.3K | |||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$3.3M | -$2.7M | $7.3M | $10.7M | $3.9M | $1.6M | -$32.9K | -$200.7K | ||||||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.5M | -$1.4M | -$1.5M | -$27.4M | $28.1M | -$3.3M | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill | $2.7M | $6.9M | $6.9M | $6.9M | $6.9M | $6.9M | $6.9M | $7.1M | $7.1M | $6.9M | $12.1M | $12.1M | $11.5M | $11.2M | $14.0M | $3.1M | $3.1M | $1.1M | ||||||||||||||||||||||||||||||||||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $0.00 | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | $8.6M | |||||||||||||||||||||||||||||||||||||||||||
| Marketable Securities Current | $17.9M | $25.2M | $24.7M | $38.9M | $35.1M | $0.00 | $3.0M | $12.4M | $19.3M | $22.6M | $22.7M | |||||||||||||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $5.8K | -$783.00 | $21.2K | $123.2K | -$19.7K | $0.00 | -$3.1K | -$35.4K | -$87.0K | -$86.6K | -$49.7K | |||||||||||||||||||||||||||||||||||||||||||||
| Marketable Securities Unrealized Gain Loss | -$35.0K | $0.00 | -$32.3K | $49.7K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $4.6M | $46.4M | $11.1M | $0.00 | $33.3M | $17.9M | $16.0M | $9.9M | $20.1M | $1.8M | $2.4M | $30.7M | $1.1M | $13.1M | $3.4M |
| Operating Cash Flow * | -$23.4M | -$16.5M | -$7.4M | -$2.6M | -$14.5M | -$13.6M | -$9.9M | -$10.8M | -$12.3M | -$10.8M | -$5.2M | -$9.0M | -$1.2M | -$12.0M | -$2.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$638.4K | $641.1K | $1.2M | -$85.1K | $249.0K | -$518.2K | -$426.8K | $1.1K | $664.2K | -$319.5K | $29.7K | -$979.6K | -$627.4K | -$566.1K | -$608.8K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$510.3K | $605.4K | $950.6K | $567.7K | -$275.8K | -$1.7M | $991.6K | $647.6K | -$3.8M | $1.6M | $270.3K | $457.3K | |||
| Net Cash Provided By Used In Investing Activities | $18.1M | -$28.7M | $0.00 | -$12.2M | $4.0K | $0.00 | -$447.8K | $8.5M | $2.5M | -$50.9K | -$985.9K | -$1.4M | |||
| Depreciation Depletion And Amortization | $0.00 | $93.4K | $103.2K | $23.3K | $566.3K | $116.4K | $69.8K | $49.7K | |||||||
| Proceeds From Issuance Of Common Stock | $46.4M | $810.0K | $0.00 | $31.1M | $10.8M | $10.8M | $31.8M | $427.5K | $4.0M | $2.3M | |||||
| Increase Decrease In Accounts Payable | -$67.3K | $849.0K | $565.2K | $79.2K | -$114.2K | $518.3K | |||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $43.5M | $19.4M | $0.00 | $25.8M | $0.00 | $10.0M | $0.00 | $2.5M | |||||||
| Payments Of Financing Costs | $0.00 | $982.3K | $162.8K | $428.5K | $126.0K | $54.3K | $15.3K | ||||||||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $5.0K | $0.00 | $9.4M | $625.7K | |||||||||||
| Payments To Acquire Marketable Securities | $25.4M | $48.1M | $0.00 | $38.0M | $0.00 | ||||||||||
| Share Based Compensation | $1.4M | $1.4M | $407.6K | $333.8K | $897.3K | $736.1K | $515.8K | $1.2M | $1.2M | $1.4M | $594.2K | $1.6M | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q3 2011 | Q2 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $0.00 | $5.0K | $33.3M | $155.2K | $10.6M | $14.1M | $0.00 | $400.0K | $200.0K | ||||||||||||||||
| Operating Cash Flow * | -$3.9M | -$1.4M | -$1.5M | -$4.7M | -$5.2M | -$3.5M | -$2.7M | -$3.3M | -$3.4M | -$4.6M | -$938.8K | -$432.9K | -$306.2K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$201.6K | $116.3K | $629.7K | $495.9K | $417.7K | $346.0K | $119.6K | $92.9K | $99.7K | $97.1K | -$15.1K | -$286.8K | $36.1K | ||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$291.4K | $28.1K | -$320.5K | -$455.5K | $250.9K | -$236.4K | -$1.1M | $797.8K | $135.4K | $319.3K | $194.3K | ||||||||||||||
| Net Cash Provided By Used In Investing Activities | $5.4M | $0.00 | $9.5M | -$22.7M | $0.00 | -$6.4K | $8.5M | $2.5M | |||||||||||||||||
| Depreciation Depletion And Amortization | $5.4K | $6.2K | $6.3K | $368.9K | $323.7K | $191.3K | $7.5K | $7.5K | $8.7K | $9.9K | $9.9K | $21.8K | $13.4K | $12.9K | $12.0K | ||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $31.1M | $10.8M | ||||||||||||||||||||||
| Increase Decrease In Accounts Payable | $349.2K | -$230.4K | $240.3K | $81.5K | -$17.7K | ||||||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $12.5M | $0.00 | $9.5M | $0.00 | $2.5M | ||||||||||||||||||||
| Payments Of Financing Costs | $238.2K | $253.8K | $187.6K | ||||||||||||||||||||||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $0.00 | $5.0K | $0.00 | ||||||||||||||||||||||
| Payments To Acquire Marketable Securities | $7.1M | $0.00 | $0.00 | $22.7M | $0.00 | ||||||||||||||||||||
| Share Based Compensation | $361.2K | $218.2K | $71.2K | $278.1K | $181.3K | $191.4K | $91.2K | $324.7K | $366.4K | $393.5K | $95.9K | $149.9K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $2.0M | $1.9M | $53.8M | $6.7M | $3.2M | -$29.11 | -$1.76 | -$2.56 | -$1.00 | -$1.00 | -$0.21 | -$0.14 | ||||
| Common Stock Shares Outstanding | 9.3M | 8.7M | 5.7M | 518.1K | 2.0M | 64.0M | 33.5M | 3.4M | 968.0K | 10.3M | 8.1M | 18.6M | 5.8M | 890.8K | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 4.2M | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | |||
| Common Stock Shares Issued | 9.3M | 8.7M | 5.7M | 2.0M | 64.0M | 33.5M | 3.4M | 968.0K | 10.3M | 8.1M | 18.6M | 5.8M | 890.8K | |||
| Earnings Per Share Basic | $-2.98 | $-2.02 | $-0.82 | $-11.20 | $-12.38 | $-0.30 | $-1.76 | $-8.21 | $-3.16 | $-1.76 | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 3.2M | 848.1K | 10.2M | 18.6M | 14.3M | 2.6M | ||||||||||
| Weighted Average Number Of Shares Issued Basic | 14.3M | 2.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.55 | -$0.70 | -$1.70 | $101.9M | $101.9M | $83.4M | $64.0M | $52.0M | $34.5M | $4.7M | $3.9M | $3.4M | $3.4M | $3.4M | $2.8M | $0.20 | -$1.00 | -$2.78 | -$0.53 | -$0.37 | -$0.62 | -$0.64 | -$0.06 | -$0.06 | -$0.18 | -$0.35 | -$0.23 | -$0.37 | $0.82 | -$2.91 | -$0.04 | -$0.02 | -$0.06 | -$0.03 | -$0.03 | -$0.03 | |||||||||||||
| Common Stock Shares Outstanding | 9.3M | 9.3M | 8.7M | 8.3M | 8.3M | 6.2M | 5.7M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 101.9M | 101.9M | 101.9M | 64.0M | 64.0M | 34.6M | 4.7M | 4.7M | 3.4M | 50.6M | 50.6M | 50.5M | 14.5M | 12.2M | 10.3M | 10.3M | 103.5M | 102.4M | 18.6M | 18.6M | 18.6M | 18.5M | 18.4M | 8.7M | 421.0M | 89.1M | 90.3M | 88.2M | 77.9M | 64.3M | 64.1M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 500.0M | 500.0M | 500.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||||
| Common Stock Shares Issued | 9.3M | 9.3M | 8.7M | 8.3M | 8.3M | 6.2M | 5.7M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 101.9M | 101.9M | 101.9M | 64.0M | 64.0M | 34.6M | 4.7M | 4.7M | 3.4M | 50.6M | 50.6M | 50.5M | 14.5M | 12.2M | 10.3M | 10.3M | 103.5M | 102.4M | 18.6M | 18.6M | 18.6M | 18.5M | 18.4M | 8.7M | 421.0M | 400.2M | 90.3M | 88.2M | 77.9M | 64.3M | 64.1M | |||||
| Earnings Per Share Basic | $-0.84 | $-0.70 | $-0.56 | $-0.55 | $-0.27 | $-0.41 | $0.65 | $-2.75 | $-1.03 | $-1.70 | $-2.06 | $-2.22 | $-5.99 | $-1.85 | $-2.81 | $-0.07 | $-0.10 | $-0.07 | $-0.60 | $-0.63 | $-0.81 | $-1.99 | $-0.82 | $-4.11 | $0.21 | $0.88 | $-0.53 | $-0.37 | |||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 8.7M | 3.8M | 518.1K | 50.6M | 50.5M | 14.7M | 13.9M | 10.3M | 10.3M | 18.6M | 18.6M | 18.6M | 18.7M | 12.9M | 5.9M | 4.1M | 2.9M | 1.2M | 117.9M | ||||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Issued Basic | 18.7M | 12.9M | 5.9M | 4.1M | 2.9M | 892.5K | 89.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.4M | $1.4M | $407.6K | $333.8K | $897.3K | $736.1K | $515.8K | $1.2M | $1.2M | $1.4M | $594.2K | ||||
| Depreciation Nonproduction | $0.00 | $93.4K | $103.2K | $97.9K | $110.4K | $68.0K | $25.3K | $8.3K | |||||||
| Professional Fees | $3.3M | $1.7M | |||||||||||||
| Warrant Expense And Fair Value Charge For Stock Sales | $2.8M | $2.9M | |||||||||||||
| Depreciation | $103.2K | $97.9K | $110.4K | $68.0K | $25.3K | ||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $0.00 | $127.5K | $50.0K | $50.0K | $1.4M | $0.00 | $262.8K | ||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $7.0M | $2.2M | $7.8M | $3.9M | $711.5K | $19.7M | |||||||||
| Additional Paid In Capital | $115.9M | $109.9M | $61.8M | $19.0M | $164.9M | ||||||||||
| Investment Income Interest | $1.3M | $1.9M | $219.4K | $62.2K | |||||||||||
| Stock Issued During Period Value New Issues | $4.6M | $46.4M | $810.0K | $5.0K | $31.8M | ||||||||||
| Stock Issued During Period Value Issued For Services | $255.7K | $127.5K | $50.0K | $50.0K | $1.4M | ||||||||||
| Stock And Warrants Issued During Period Value Net Issuance Costs | $31.1M | $10.3M | $11.9M | $10.4M | |||||||||||
| Interest Paid Net | $40.1K | $112.8K | $677.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q3 2011 | Q2 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $291.7K | $497.0K | $361.2K | $271.2K | $578.6K | $218.2K | $109.2K | $62.3K | $71.2K | $82.4K | $164.4K | $297.3K | $181.3K | $279.5K | $113.4K | $191.4K | $145.3K | $149.1K | $91.2K | $327.4K | $319.8K | $324.7K | $366.4K | $393.5K | |||||||||||||||||||||
| Depreciation Nonproduction | $0.00 | $0.00 | $0.00 | $19.1K | $23.8K | $24.4K | $24.2K | $27.0K | $27.0K | $18.2K | $34.4K | $18.3K | $26.7K | $26.7K | $28.0K | $27.4K | $5.8K | $6.6K | $5.8K | $5.8K | $7.9K | $2.2K | $1.9K | $2.0K | |||||||||||||||||||||
| Professional Fees | $294.4K | $384.6K | $131.7K | $576.7K | $290.6K | $143.1K | $428.7K | $428.7K | $1.2M | $542.1K | $484.4K | $359.2K | |||||||||||||||||||||||||||||||||
| Warrant Expense And Fair Value Charge For Stock Sales | $783.9K | $141.3K | $149.9K | $631.4K | $2.3M | $1.3M | $1.9M | $1.9M | $331.5K | $382.0K | $635.2K | $806.9K | |||||||||||||||||||||||||||||||||
| Depreciation | $0.00 | $24.4K | $27.0K | $18.3K | $28.0K | $6.6K | |||||||||||||||||||||||||||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $0.00 | $487.5K | $0.00 | $130.0K | |||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $7.0M | $0.00 | $2.2M | $7.5K | $7.6M | $711.5K | |||||||||||||||||||||||||||||||||||||||
| Additional Paid In Capital | $115.6M | $115.3M | $110.2M | $109.5M | $109.3M | $62.3M | $61.6M | $166.0M | $166.0M | ||||||||||||||||||||||||||||||||||||
| Investment Income Interest | $318.8K | $368.1K | $409.0K | $646.2K | $678.4K | $80.6K | $47.7K | $17.7K | $35.4K | $21.5K | |||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $46.4M | $810.0K | $5.0K | $31.1M | |||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $255.7K | $25.0K | $487.5K | ||||||||||||||||||||||||||||||||||||||||||
| Stock And Warrants Issued During Period Value Net Issuance Costs | $0.00 | $10.3M | $134.8K | $5.6M | $10.4M | ||||||||||||||||||||||||||||||||||||||||
| Interest Paid Net | $0.00 | $0.00 |
Most recent annual filing with the SEC: March 13, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.